Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets

Haematologica

Volumn 98, Issue 5, 2013, Pages 793-801

  Chen, Wei Fan ^a,b   Lee, Jie Jen ^c   Chang, Chao Chien ^b,d   Lin, Kuan Hong ^e   Wang, Shwu Huey ^a   Sheu, Joen Rong ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PADGEM PROTEIN; PROTEINASE ACTIVATED RECEPTOR 4; SPHINGOMYELIN PHOSPHODIESTERASE; THROMBIN; N-ACETYLSPHINGOSINE; PROTEASE-ACTIVATED RECEPTOR 4; PROTEIN BINDING; SPHINGOSINE; THROMBIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CALCIUM MOBILIZATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MESENTERY BLOOD VESSEL; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLISM; THROMBOCYTE;

BLOOD PLATELETS; CERAMIDES; HUMANS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET ACTIVATION; PLATELET AGGREGATION; PROTEIN BINDING; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TANDEM MASS SPECTROMETRY; THROMBIN;

EID: 84877044874     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.072553     Document Type: Article

References (34)

1. Hirano K. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2007;27(1):27-36.
2. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103(6):879-87.
3. Voss B, McLaughlin JN, Holinstat M, Zent R, Hamm HE. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide- 3 kinase signaling axis. Mol Pharmacol. 2007;71(5):1399-406.
4. Mazharian A, Roger S, Berrou E, Adam F, Kauskot A, Nurden P, et al. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization. J Biol Chem. 2007;282(8):5478-87.
5. Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, et al. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood. 2000;95(7):2289-96.
6. Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood. 2004;104 (5):1361-8.
7. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. Ligandspecific glucocorticoid receptor activation in human platelets. Blood. 2005;106(13):4167-75.
8. Malaver E, Romaniuk MA, D'Atri LP, Pozner RG, Negrotto S, Benzadón R, et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost. 2009;7(1):1333-43.
9. Steinbrecher UP, Gómez-Muñoz A, Duronio V. Acid sphingomyelinase in macrophage apoptosis. Curr Opin Lipidol. 2004;15(5):531-7.
10. Romiti E, Vasta V, Meacci E, Farnararo M, Linke T, Ferlinz K, et al. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol Cell Biochem. 2000;205(1-2):75-81.
11. Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Cell Biol. 2004;82(1):27-44.
12. Simons K, Ikonen E. How cells handle cholesterol. Science. 2000;290(5497):1721-6.
13. Doyle T, Chen Z, Muscoli C, Obeid LM, Salvemini D. Intraplantar-injected ceramide in rats induces hyperalgesia through an NF- {kappa}B- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway. FASEB J. 2011;25(8):2782-91.
14. Hsiao G, Lee JJ, Lin KH, Shen CH, Fong TH, Chou DS, et al. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies. Cardiovasc Res. 2007;75(4):782-92.
15. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood. 1999;93(12):4222-31.
16. Hsu YF, Sheu JR, Lin CH, Yang DS, Hsiao G, Ou G, et al. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38 MAPK in HT29 colon cancer cells. Biochim Biophys Acta. 2012;1820(2):104-15.
17. Wang SH, Yang WB, Liu YC, Chiu YH, Chen CT, Kao PF, et al. A potent sphingomyelinase inhibitor from Cordyceps mycelia contributes its cytoprotective effect against oxidative stress in macrophages. J Lipid Res. 2001;52(3):471-9.
18. Lu WJ, Lee JJ, Chou DS, Jayakumar T, Fong TH, Hsiao G, et al. A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/ cyclic GMP. J Mol Med. 2011;89(12):1261-73.
19. Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain. 2008;131(12):3256-65.
20. Chen BC, Chang HM, Hsu MJ, Shih CM, Chiu YH, Chiu WT, et al. Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway. J Biol Chem. 2009;284(31):20562-73.
21. Bugaud F, Nadal-Wollbold F, Lévy-Toledano S, Rosa JP, Bryckaert M. Regulation of c-jun- NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood. 1999;94(11):3800-5.
22. Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, Jin J, et al. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood. 2002;99(10):3629-36.
23. Hisano N, Yatomi Y, Fujino MA, Igarashi Y, Kume S, Ozaki Y. Quantification of sphingosine derivatives in human Platelets: inducible formation of free sphingosine. J Biochem. 1998;123(2):263-8.
24. Simon CG Jr, Gear AR. Sphingolipid metabolism during human platelet activation. Thromb Res. 1999;94(1):13-23.
25. Devillard R, Galvani S, Thiers JC, Guenet JL, Hannun Y, Bielawski J, et al. Stress-Induced Sphingolipid Signaling: Role of Type-2 Neutral Sphingomyelinase in Murine Cell Apoptosis and Proliferation. PLoS ONE. 2010;5(3):e9826.
26. Sawai H, Domae N, Nagan N, Hannun YA. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem. 1999; 274(53):38131-9.
27. Marchesini N, Luberto C, Hannun YA. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J Biol Chem. 2003; 278(16):13775-83.
28. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604-16.
29. Marchesini N, Osta W, Bielawski J, Luberto C, Obeid LM, Hannun YA. Role for mammalian neutral sphingomyelinase 2 in confluence- induced growth arrest of MCF7 cells. J Biol Chem. 2004;279(24):25101-11.
30. Li X, Becker KA, Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem. 2010;26(1):41-8.
31. Brass LF. Thrombin and platelet activation. Chest. 2003;124(3):18S-25S.
32. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008;8(11):837-48.
33. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, et al. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 1997;88(4):521-30.
34. Coulon L, Calzada C, Moulin P, Véricel E, Lagarde M. Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med. 2003; 35(6):616-25.